Dosentrx Ltd.
New Form D on file · 2026-03-19 · the record
Dosentrx Ltd. filed a Form D with the Securities and Exchange Commission on 2026-03-19.
Dosentrx Ltd. filed a Form D notice of an exempt securities offering with the SEC on March 19, 2026. The filing reports $1.78M sold. Its industry group is Pharmaceuticals. It names Mark Summers (Executive Officer), Jon Roberts (Director), Daniel Beck (Director) (SEC Form D, March 19, 2026).
Sell to companies like Dosentrx Ltd? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
88 companies raised this week, 1 had other signals.
Companies that just raised money, and the people to call. Before you unlock: the company, the amount, the date and what is inside (for example 2 people, phone, LinkedIn). After: the officers and directors the filing names with their roles, how to reach the company, and a person's email only when we found one.
| fal - Features & Labels, Inc. | $1B | AI and software |
| fal - Features & Labels, Inc. | $350M | AI and software |
| SIERRA INTERNATIONAL NETWORK INC | $300M | AI and software |
| Zai Lab Ltd | $250M | Biotech |
| Databento Inc. | $100M | AI and software |
Is this your company?
New Form D on file · 2026-03-19 · the record
Pitching, partnering or investing alongside them? See who really runs and owns Dosentrx Ltd.
Free to see. No signup.
More on the people and the money behind Dosentrx Ltd., from the filings we hold.
Cedar Point Capital LLC received sales compensation on this raise and on 8 other raises we hold, nearest in date first:
Pharmaceuticals raises filed within 90 days of this one, largest first.
Get an email when Dosentrx Ltd. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
We'll show it in your MentionFox inbox when Dosentrx Ltd. raises, hires or launches. No email unless you switch it on.
Watch Dosentrx Ltd. →Get the full cited report on Dosentrx Ltd.
What the filing shows about Dosentrx Ltd.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC
A Full Report on Dosentrx Ltd.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
The weeks after a raise are when investors, other founders and press look Dosentrx Ltd. up. FoxPlug is your startup's chief of staff: it reads your whole stack and tells you what to fix, what to say and what to skip, for founders shipping with Claude Code, Codex or Cursor. It drafts your monthly investor update from your real numbers, and its free tools need no account. GetFoxChat puts an AI operator on Dosentrx Ltd.'s own site, named as you like, so the visitors this record sends you don't read one page and leave.
The filing gives Dosentrx Ltd.'s address as 1 Hamaayan St, Modiin Maccabim Reut, L3 7177874.
Saved here on this device in the meantime, so nothing is lost either way.
This is the company's own disclosure. A payment disclosed on a Form D is a disclosed use of proceeds, not a finding of wrongdoing.
Dosentrx Ltd. is a registered filer with the SEC (CIK 2121365) and has filed since 2026-03-19. 1 filing is on record, the latest on 2026-03-19.
A filing shows the company exists and what it reports about itself. It is not an audit or a rating.
Dosentrx Ltd.'s Form D of 2026-03-19 names Mark Summers, Jon Roberts, Daniel Beck and 4 more as its officers, directors or promoters.
Its new offerings report $1.78M sold across 1 offering, as its own filings state.
Trailing twelve months. 157 filings in Pharmaceuticals, totalled by week. The dot is this raise, $1.78M, on the same scale — one filing against the whole group's total, so it sits low by construction.
Mark Summers is named as Executive Officer on the Form D that Dosentrx Ltd. filed with the SEC on 19 March 2026, one of 7 people that filing names.
Jon Roberts is named as Director on the Form D that Dosentrx Ltd. filed with the SEC on 19 March 2026, one of 7 people that filing names.
Daniel Beck is named as Director on the Form D that Dosentrx Ltd. filed with the SEC on 19 March 2026, one of 7 people that filing names.
Gerald Lieberman is named as Director on the Form D that Dosentrx Ltd. filed with the SEC on 19 March 2026, one of 7 people that filing names.
Alan Paz is named as Executive Officer and Director on the Form D that Dosentrx Ltd. filed with the SEC on 19 March 2026, one of 7 people that filing names.
Frank Sheehy is named as Director on the Form D that Dosentrx Ltd. filed with the SEC on 19 March 2026, one of 7 people that filing names.
On the filing as: Executive Officer.
Liron Levi-Gabay is named as General Counsel on the Form D that Dosentrx Ltd. filed with the SEC on 19 March 2026, one of 7 people that filing names.
7 people named on the filing — 3 holding an executive role and 4 as directors only.
Named as of the 2026-03-19 filing. Titles and locations are exactly as the filing states — not independently confirmed elsewhere.
No investor is drawn from a Form D — the form states how many invested and never who.
What the filing shows about Dosentrx Ltd.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC
A Full Report on Dosentrx Ltd.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Dosentrx Ltd. covers
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
You land back on this company when you are in.
Not ready to upgrade? Keep this one in view instead.
Watchlist Dosentrx Ltd.You get an alert in MentionFox the next time this company shows up.
Sourced from the filing index on sec.gov.
Each opens in a new tab, filled in for Dosentrx Ltd.. With no account yet, you sign up free and land on the result.
Share your raise. This card is drawn from the company's own Form D filing, and sharing needs no account.

https://mentionfox.com/funding/dosentrx-ltd-form-d-26000001